Sources of variation in assays of aspartate aminotransferase (EC 2.6.1.1) activity were examined in an interlaboratory survey and through an examination of materials used as calibration materials in these assays. 
and deviated from values expected from this procedure. The average coefficient of variation (CV) with these kits was >20%.
Automated continuous-flow procedures with use of diazonium salt showed the best precision (av CV, <10%). However, the automated continuous-flow malate dehydrogenase/NADH coupled method produced an average CV >20%. Results from each of the automated methods were related to a reference malate dehydrogenase/NADH coupled continuous kinetic assay method by temperature relationships alone. Mean values from manual diazonium salt procedures were 1.7-fold greater than similar reference values (av CV was 18%). The higher results were attributed to the use of poorly-defined units and to an artifact caused by chromophore stabilizers in this procedure when aqueous samples are used. The average CV in continuous kinetic methods varied among kit manufacturers, ranging from 6 to 28% for the specimen of highest activity.
Variations in results were much larger at 366 nm than at 340 nm. Interassay relationships of these methods are presented. Concentrations of pyruvate in commercially available calibration materials differed between manufacturers, varied in stability, and deviated from the expected concentration. For some colorimetric assays the precision attained on reported absorbance values for the enzyme specimens was of the same order of magnitude as that for pyruvate standards. Other sources of error are revealed by the interlaboratory survey. The value of commercially available sources of enzyme activity as calibration or control materials was assessed by evaluating the following properties: activity at suboptimal concentrations of L-aspartate or 2-oxoglutarate, temperature effects, preincubation lability owing to aspartate and phosphate, pyridoxal phosphate saturation, contamination with glutamate dehydrogenase, and manufacturer's rated activity. These properties are compared to those of human cytoplasmic enzyme in a human serum matrix.
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Keyphrases:
"kit" methods #{149} enzyme activity #{149} quality control #{149} variation and error, sources of Determination of AST' activity in human serum has proved to be a valuable aid to diagnosis and to assessing the severityof many disorders and pathological conditions (1) (2) (3) , and during the past 20 years this determination has become extensively used by clinical laboratories (4, 5) . However, poor intra-and (11) (12) (13) .
These variable errors contribute greatly to interlaboratory imprecision.
Modification
of AST assay methods. suits is precluded by such changes, whether direct (in the assay method) or indirect(inthe method used to rate serum calibrationstandards (20) (21) (22) .
These are frequently ignored in the routine clinical laboratory, and manufacturers of some kits actively discourage the use of specimen blanks (e.g., 23). Laboratories that perform blank corrections and those that do not may (invalidly) be treated statistically as a single group. Moreover, lyophilized sera, which are often used in interlaboratory surveys, frequently are atypically turbid and yield far higher blanks in colorimetric dye-coupled procedures than most native sera. Ignoring this difference will also distort the survey results.
To achieve the most accurate interlaboratory comparison possible, we have comprehensively examined the measurement of AST activities by laboratories licensed by the New York State Department of Health. Purified enzyme of human origin was used as the survey material.
In evaluating the results, we have grouped them both by method and by calibration procedure.
Because of the predominance of methods requiring serum or chemical calibration, we have also examined several materials routinely used to calibrate the assay of AST activity. AST to pooled human serum, which was then dispensed into 5.0-ml aliquots and lyophilized. The AST activity of the reconstituted sample was 98 U/liter. About 80% of this activity was due to the addition of purified enzyme and 20% to endogenous serum AST.
Materials and Methods
We also examined pyruvate calibration materials supplied with the two most widely used kits (Sigma and Dade). These were used for evaluation only, not for calibration of assays in our laboratory. (39, 40) . Mean values and SD are shown to the nearest unit by each method, but CV were calculated by using these figures to the nearest tenth of a unit.
Results from two laboratories using grossly madequate instrumentation were omitted from the survey (see Discussion).
All other participant results, including those >3 SD from the mean, were used in the calculations.
We feel that this procedure more appropriately describes the actual survey results than does the rejection of outliers.
Review of Methods in Use
To facilitate interpretation of the intermethod comparisons, we present a brief review of the methods most commonly used in the present survey. Excellent reviews and comparisons of some methods a!-ready exist (19, 22, 41) (42, 43) . The lower substrate concentrations of the technique of Henry et al. were adopted in our reference procedure so that it would be more similar to the majority of kinetic assay methods of both participant and reference laboratories. We have observed no significant difference between the values obtained by the DGKC method at 30 #{176}C and by our modification of the procedure of Henry et a!. (P >0.10; n = 22 sera) or when purified human cytoplasmic AST was assayed. However, the DGKC results were about 10% higher in assays of purified human mitochondrial AST.
Colorimetric:
2,4-dinitrophenylhydrazine-coupled. In the procedure published by Tonhazy et a!.
(44) and modified by Sigma (23) The oxalacetate formed after a fixed incubation period (usually 20 mm) is quantitated in these methods by using diazonium dyes (20, 22, 46) . These dyes are more selective than is dinitrophenylhydrazine, and other oxo-acids, such as pyruvate, do not react, the result being increased specificity for oxalacetate. Because pyruvate cannot be used, oxalacetate calibration materials were used in the original procedure of Babson et a!., but these are unstable, and serum-based calibration is now common. The protein concentration in the sample affects the assay (47), and the substrate concentrations specified by Babson et al. (20, 46) 
Results

Reference Laboratories
Specimens were shipped to eight reference laboratories in the same manner as specimens shipped to participant laboratories. (20, 56) , gave results averaging 54% higher than those reported by the reference laboratories using the method of Babson et al. (Figure 1) Table 4 . The SMA diazo procedure used by 40 (13%) of the participants showed good precision (av CV, 9.7%). The results appeared to be independent of the serum calibrator used. Precision was poorer in the MDH/NADH coupled 340-nm method, where the average CV was 25.3%. Mean values were appreciably lower than for the diazo method. Participant performance by these two methods is plotted against reference kinetic values in Figure 3 . Five laboratories using the SMA 12/30 procedure reported values that agreed with the 340-nm method. AutoAnalyzer single-channel procedures vary among laboratories by method or modifications, or both, and were grouped by calibration procedure. Least-squares regression linear models comparing participant and reference data with results from the reference kinetic method are shown in Table 5 .
Commercial Calibration Materials
Sera. Commercial lyophilized sera, used as calibration materials by 40% of participant laboratories, were examined for their similarity to the behavior of serum-based human erythrocyte AST (Table 6 ). Control activities of all 10 commercial materials and serum-based AST were determined by quintuplicate assays on each of two vials. Each material was reconstituted with the manufacturer's recommended vol- ume of distilled de-ionized water, completely dissolved by gentle inversion, allowed to stand at room temperature for 1 h, and again gently mixed by inversion. The amount of apo-AST in these materials was examined by reconstituting individual vials of each serum with a freshly prepared solution of pyridoxal phosphate (20 pmol/liter of distilled water), incubating at room temperature for 1 h, and assaying by the reference kinetic procedure. All commercial materials except Versatol E showed a significant (P <0.05) increase when supplemented with pyridoxal phosphate. An 11% increase was observed with the serum-based AST. All materials were also assayed by the reference kinetic assay, changed only by halving the concentration of 2-oxoglutarate (to 3.4 mmol/liter) or L-aspartate (to 66.5 mmol/liter). (Table 6 ) show a significant (P <0.001) decrease in AST activity for all materials tested.
The effect of temperature on each of the materials was examined by quintuplicate assays at 25, 30, and 37 #{176}C. Data were entered as ln AST activity and reciprocal of temperature (K1), and the Arrhenius slope was found by least-squares regression, linear model. The slope for the human serum-based AST was -5.93 X iO, in very close agreement to our previously measured slope of -5.84 X iO for purified erythrocyte AST (24) and the estimates of Henry et a!. for human serum (27). Correlation coefficients for all estimates were excellent, ranging from 0.989 to 1.000. Arrhenius slopes for commercial materials varied from -5.70 X iO to -6.7 X iOn. Except in the case of Precipath, Arrhenius slopes tended to increase with increasing AST activity of the serum material, a finding consistent with the fact that a larger proportion of the AST in these materials is of nonhuman origin and has a different temperature response curve than does the enzyme of human origin.
Manufacturer These conversions have been experimentally verified in our laboratories with sera of both normal and above-normal activity and with purified cytoplasmic AST. All sera investigated were assayed by both our kinetic assay and the method of Babson et al. in our laboratory.
The results are shown in Table 7 , as are the observed ratios between the kinetic assay and the value stated by the manufacturer on the package insert; ideally, the ratio should be 1.0. Also shown are the ratios between values obtained by the two assays performed in our laboratory; here the ratio ideally should be about 1. 
As defined by Babson et al.(20).
#{176} Idealratio, 1.1. These materials were also examined for chromogenic activity with 2,4-dinitrophenylhydrazine in a manner similar to the Reitman-Frankel procedure. These results, plotted against measured pyruvate concentrations in Figure 4 , indicate that the only material reacting to 2,4-dinitrophenylhydrazine in these commercial calibration materials is pyruvate.
Discussion
The data presented ( Tables  3, 4 The typical CV for laboratories in our routine proficiency testing program is <10% for lyophilized serum samples for other determinations (pH, glucose, urea, cholesterol, calcium). However, the interlaboratory CV measured for human AST and lactate dehydrogenase in lyophilized serum-based samples in our program is near 30% (7). Thus, while the values for CV encountered in the present study with purified enzymes are disturbingly high, they are generally lower than those found for the assay of AST activity in lyophilized sera, which appears to confirm our contention that the use of serum-based materials and grouping of data less rigorously than in the present survey lead to overestimates of interlaboratory variation.
Although Activity values of test specimens were then read from each of the three computer-generated equations and reported absorbance values, and mean and SD values were calculated for each curve. These data are shown for square and cubic models in Table 9 ; linear standard curves are not obtained in this assay, and these values are omitted.
In each case, the values reported by the laboratories show CV less than those obtained with computer models, indicating that errors in reading standard curves were not a significant source of error in this survey. Mean values were not significantly different for the two computer-generated models.
From the type of data obtained in this survey it is difficult to attribute variation to particular sources of instrumental error. Maclin et al. (62) , who had access to preliminary data from this survey, have comprehensively examined potential sources of instrumental error in kinetic enzyme assays. While these authors speculate that a potential 50% of the error found for one group of laboratories (those doing continuous kinetic assay of sample no. 3) may be attributable to instrumental errors, they concur with us that a true estimate of instrumental error is possible only with "a detailed evaluation and rigorous statistical analysis of each instrument used in the survey." A survey of spectrophotometric instrumentation in the same laboratories has been made in connection (11, 12, 17, 19, 66) , the present study (Table 8) (70), which accumulates in the Reitman-Frankel assay but is reduced to malate in the continuous kinetic assay. We have confirmed this product inhibition with isoenzymes of human AST. Because of these three ambiguities it is difficult to firmly establish which concentration of sodium pyruvate is "correct" or gives rise to a uniform correlation with a kinetic procedure. These difficulties are also discussed by Frankel (45) .
Despite these pitfalls, we found the ratio between the results in Reitman-Frankel units obtained from the reference laboratories (Tables 2, 5 ) and the reference kinetic units to be the same as that expected for Karmen units at 25 #{176}C. This is consistent with our previous observations (24) regarding the behavior of human cytoplasmic AST in these two methods and supports the observations of Witter and Grubbs (67) that the units by the Reitman-Frankel procedure are indeed equivalent to those described by Karmen at 25 #{176}C. Our findings also support the calibration material pyruvate concentrations and corresponding activity assignments proposed by Reitman and Frankel (21, 45) .
While calibrationmaterials obtained directlyfrom the manufacturer showed good interlotagreement, variability was greater with the same materials obtained from participant laboratories (Table 8) , indicating that storage conditions in the supply chain and in the laboratory may affect pyruvate concentration. Good agreement between 2,4-dinitrophenylhydrazine reactivity and enzymatically measured pyruvate (Figure 4) indicates that pyruvate is the only chromogenic substance in these calibration materials. We further examined the use of chemical standardization by obtaining the absorbance values for dinitrophenylhydrazones formed with pyruvate calibration materials and with the survey samples as reported by the largest group in our survey using the same method and instrumentation (23 laboratories using the Sigma kit with Coleman Jr. photometers). The results (Table 10) Figure 3) . These values are in agreement with the relativeactivitiesat the three temperatures, based on the Arrhenius behavior (24) of cytoplasmic AST: 2.5 (45 #{176}C/30 #{176}C) and 1.54 (37 #{176}C/30 #{176}C). Laessig et al. (10) , in a survey conducted by the Wisconsin Department of Health, compared results from these automated methods and from the method of Karmen, in micromolar units at 30 #{176}C, and found average ratios of 3.2 and 2.54 for the diazo and 340-nm values, respectively, vs. U/liter in the Karmen assay. Adjusting for differences in substrate concentration between the Karmen and our procedure, these ratios would be 2.7 and 2.1, respectively, in general agreement with the ratios we obtained. Any differences between the ratios may be attributed to the differing enzymes used in the surveys: cytoplasmic AST of human origin was used in the present survey, and commercially obtained calibration sera, with at least a portion of its AST activity of nonhuman origin, was used in the Wisconsin survey.
The 340-nm method (av CV, 25%) was markedly less precise than the diazo technique (av CV, 10%), a difference significant at F005 for specimen 1 and at F0005 for specimen 2. The newness of the 340-nm method-it had been introduced just before the survey-might have contributed to its lessened precision. A survey conducted by our laboratories in September 1974 revealed an average CV of 17% with the 340-nm method (n = 144 on four specimens) and 8% with the diazo method (n = 20 on three specimens), showing 340-nm precision improved but stillnot equivalent to that for the diazo method of even the earliersurvey. The 1974 survey, conducted with samples containing purifiedhuman cytoplasmic AST in a bovine serum matrix, showed ratios between either the diazo or 340-nm method and our kineticassay of 2.82 and 2.01,respectively.
There were no interferences from artifacts attributable to varying protein content (47) in these procedures, which require dialysis, for the survey specimens were prepared in a polyvinylpyrrolidone-contaming diluent, which apparently compensated for the very low protein. Participant data (Tables 4, 5; Figure 1) show that the diazonium salt procedure gave resultsthat were about 50% higher than units reported by the reference laboratories using the same technique; and the mean of participant data, rather than being about 150% (allowing for the increased color caused by the absence of protein) is 259% that of our kinetic method (Table 5 ). This increase is not attributable to sample blank, which was negligible (Table 4) , and only a portion of the higher value can be ascribed to the lack of protein in these methods. Furthermore, there is no contribution by the latter effect in the comparison of two diazonium salt procedures (Figure 1) , where the oxalacetate decarboxylation should be lessened in each.
A major difference between the participant and reference laboratories lies in the type of standardization: oxalacetate for the reference laboratories and preassayed commercial sera for the participant laboratories.
Comparison of rated insert AST values for 11 randomly chosen lots of Versatol E (Table  11) shows that TransAc units,rather than being 10% less than Karmen units-as found by Babson et al. (20) , published by General Diagnostics (76) and reconfirmed in our laboratory-average 11% higher than karmen units. Comparison between Reitman-Frankel units, which should be numerically equal to Karmen units (but are not),and TransAc units shows the latterto be 30% higher. Inconsistencies between the assigned units can also be observed in the ratios of activityby these three assay techniques. Thus itappears the increased numerical values of participant data are due in large part to the use of calibration sera in which values by the diazonium saltprocedure are inconsistentwith the ratiofound by Babson et al. (20, 76) and reconfirmed by our laboratory (24).
Differences in the colorimetricportion of the assay may also give rise to the apparent discrepancy be- We therefore examined the effects of HC1/Lipal stabilization on the results of this assay, and reconfirmed the studies of Babson and Phillips (77) showing that HC1 decreased the absorbance resulting from the original procedure by about 13% and that this effect could be reversed by the addition of Lipal. While their studies (77) were limited to the use of Versatol calibration sera, we found these observations to be true both for other commercial sera and for native human sera. However, when aqueous enzyme materials or aqueous solutions of oxalacetate were used, we found a 30% increase in absorbance due to Lipal. The somewhat better precision in the Eskalab results may be due to use of uniform instrumentation; all of these laboratories used the Smith Kline Alpha instrument. These data show that it is quite possible to achieve a CV of <10% with kinetic assays in interlaboratory studies. It is doubtful that the improved precision is due solely to the use of an assay temperature of 37 #{176}C, which yields a greater absorbance change than does 30 #{176}C, for precision was not improved in the laboratories using other reagent systems and temperatures greater than 30 #{176}C (n = 6). Moreover, the six laboratories using the Boehringer Mannheim Karmen kit (52) and 25 #{176}C showed better precision than did the 13 laboratories that used this kit at various other temperatures: sample 1, 50 ± 5 U/liter; sample 2, 98 ± 12; sample 3, 22 ± 4 (av CV, 13.5%). Two laboratories used this kit with instrumentation inadequate for rate determinations at 340 or 366 nm: Coleman Jr. II A photometers, round cuvettes, and uncertain temperature control. The inadequacies of such systems for rate determinations have been stressed by many workers (19, 30, 64, 65, 79, 80) . Not unexpectedly, the results from these two laboratories failed to relate to any expression of enzyme activity, and they have been omitted from all calculations.
This brings into focus the lack of fundamental understanding in some laboratories of the rudiments of such analyses. The lower precision observed with the Boehringer Mannheim Karmen kit is undoubtedly due to the measurement of absorbance change at 366 nm by 11 of the 13 laboratories.
All but two of these 11 laboratories used the Tecometer R (formerly distributed by Boehringer Mannheim), an early-generation photometer with a wide half-bandwidth and maximum intensity at about 366 nm. The decreased sensitivity at this wavelength and increased error caused by changes in half-intensity bandpass are well documented (64, 65, 79, 80) . The results from the two laboratories that used this kit procedure at 340 nm showed excellent agreement with the values expected from a Karmen assay at 30 #{176}C: sample 1, 40 and 44 U/liter; sample 2, 84 and 86; sample 3, 14 and 20. This was confirmed in our laboratory by assaying patients' sera and purified AST by the Boehringer Mannheim Karmen kit and our reference procedure at 340 nm. All kit values were 80 ± 4% of those by our method, showing equivalence between this kit procedure and the original Karmen method. Absorbance changes in all other participant kinetic systems were determined at 340 nm. Thus, a significant source of error is measurement of absorbance change at 366 nm with wide bandwidth or use of a poorly calibrated 366-nm fixed-wavelength photometer. These errors are particularly acute in determination of AST, because the MDH/ NADH coupled assay routinely commences at absorbances 1.5 (at 340 nm) and significant absorbance changes are manifested by small changes in transmittance. Such errors would not be so pronounced in NADH-generating systems (e.g., lactate-to-pyruvate lactate dehydrogenase assay methods).
Errors Owing to Serum Calibration Standards
Differences between the molecular properties of human enzymes and those of animal origin render the latter at best a compromise in the quality control and standardization of enzyme assays (12, 15, 17, 19, 24, 30, 63) . The uneven response of the AST activity in commercial serum calibrationmaterials to changes in substrate concentrations isclearlyshown in Table  6 . The large increasein activitywhen pyridoxal phosphate is added to the commercial serum materials indicates that a large portion of AST in these samples exists in the apoenzyme form, in some cases >50%. It is interesting to note the only material showing full activity without added pyridoxal phosphate (Versatol E) was found by other authors to be pyridoxaldeficient (81), indicating a difference between lots of the same commercial material. Previous studies have noted discrepancies between the manufacturer's values supplied on the package insert and the actual enzyme activities of these materials (11-13). In the present study none of the 10 materials examined showed enzyme activities outside ±13%, or ±12 U/liter, of the rated value (Table 7) .
The situation has apparently improved, but it is still far from adequate. These serum materials were also assayed by the method of Babson et al. and the ratios between the activities found by the two-point colonmetric and the continuous kinetic assays were calculated (Table 7) . From the expected relationships between the Babson et al., Karmen, and Henry et al. assays, this ratio should be about 1.1 (see above). Deviation from this ratio may well be due to the differences between the interassay response of the enzyme of human origin, for which the observed ratio was obtained, and the nonhuman-origin enzymes used to supplement the commercial materials. Thus the two materials with greatest AST activity (Precipath E
and Versatol E)-and presumably the greatest amount of nonhuman-origin AST-give the greatest significant deviation from the expected ratio.The deviation is probably not caused by the nonlinearity of the diazonium saltassay (20, 22, 82) , because AST of human origin gives the desired ratio at activities of about thismagnitude. These comparisons of AST of human and nonhuman origins are of more than theoretical interest. When a patient's sample activity is compared to the activity of a nonhuman-origin enzyme, an error owing to the difference in the response of the two enzymes is implicitly-but inexorably-conferred to the data for the patient.Use of a human-origin enzyme control material will detect these errors, but such materials are not in general use, and the commonly used control materials, with the same nonhuman enzyme, will only further mask the errors.
Envoi
Since the report of Belk and Sunderman (83) in 1947, there have been numerous confirmations of poor interlaboratory agreement in many areas of clinical chemistry.
The present survey was intended as an in-depth account of the variations and the sources of these variationsin the assay of one clinically important enzyme. This approach is particularly difficult in the area of clinical enzymology, where unstable standards that only marginally mimic patients' sera, calibration materials rated in uninterpretable units, and assays that are modified without proper concern for the analyte enzyme are commonplace. Perhaps, with recent federal action (84), many of these unnecessary vagaries will be corrected, and increased communication between interested groups and societies will further catalyze this process. Until that time, enzyme surveys such as the present one will have to flounder in the thicket of methods, calibration materials, chromogenic reagents, and modifications. These efforts are not unlike those of another exploration Ado. Gun. Chem. 1,313 (1958 Methods Enzymol. 27B, 866 (1971) .
